Shaojun Lin

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

Yunpeng Yang, Song Qu, Jingao Li et al. · The Lancet Oncology · 2021 · 429 citations

Medicine, Clinical Trials, Immune Checkpoint Inhibitor +8

Nasopharyngeal Carcinoma Treated With Reduced-Volume Intensity-Modulated Radiation Therapy: Report on the 3-Year Outcome of a Prospective Series

Shaojun Lin, Jianji Pan, Lu Han et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 260 citations

Nasopharyngeal Carcinoma Treated, Health Sciences, Radiation Therapy +8

Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases

Shaojun Lin, Jiade J. Lu, Lu Han et al. · BMC Cancer · 2010 · 162 citations · Full text

Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin

Shaojun Lin, Jianji Pan, Lu Han et al. · Radiotherapy and Oncology · 2014 · 130 citations

Radiation Therapy, Medicine, Update Report +8

Intensity-Modulated Radiation Therapy in the Salvage of Locally Recurrent Nasopharyngeal Carcinoma

Sufang Qiu, Shaojun Lin, Ivan Weng Keong Tham et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 122 citations

Radiation Medicine, Intensity-modulated Radiation Therapy, Radiation Therapy +8